Immatics NV reports third quarter net loss of $59.3 million

Immatics NV reported a net loss of $59.3 million for the third quarter ended September 30, 2025, compared to a net loss of $6.2 million for the same period in 2024. Total revenue from collaboration agreements was $6.1 million, down from $59.4 million in the prior year quarter, primarily due to a one-time revenue event related to the termination of the IMA401 collaboration by Bristol Myers Squibb in 2024. Cash and cash equivalents, along with other financial assets, totaled $505.8 million as of September 30, 2025, compared to $709.7 million as of December 31, 2024, reflecting operational cash burn and unrealized foreign exchange losses. The company announced the appointments of Venkat Ramanan as Chief Financial Officer and Amie Krause as Chief People Officer in October 2025. Immatics remains on track for a planned BLA submission for anzu-cel in the first half of 2027 and a potential launch in the second half of 2027. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immatics NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW1001139200-en) on November 17, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)